SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Roche Receives CE Mark for cobas Smart e Immunoanalyser

Roche says the CE Mark completes its cobas smart e immunoanalyser portfolio for healthcare settings ranging from small clinics to large hospital laboratories.

Related stories